Actinogen Medical Limited (ASX:ACW) Annual Report 2020



The latest annual report of Actinogen Medical Limited (ACW) was published on 30 Jun 2020. An annual report is a document that public corporations must provide annually to shareholders that describes their operations and financial conditions. Typically, an annual report will contain sections such as General corporate information, Operating and Financial highlights, Letter to shareholders from the CEO, Financial statements etc.

Key Statistics - ACW Annual Results

Amounts in AUD

Total Revenue
3.52M
Gross Profit
3.52M
EBIT
-5.4M
Net Tangible Assets
7.54M
Net Income
-5.33M
Capital Expenditures
-22.76k

ACW Income Statement 2020 Annual Report

As per the latest Income Statement of ACW, the Net revenue decreased by $-1.35M (-28%) compared to the previous period. The operating income in 2020 increased by $4.21M (44%). The net income as per the annual report was -5.33M which increased by $4.56M (46%) compared to previous year.

Income Statement Report (2020/2019)

20202019
Total Revenue3.52M4.86M
Gross Profit3.52M4.86M
Operating Income-5.4M-9.61M
Income Before Tax-5.33M-9.89M
Net Income-5.33M-9.89M

Balance Sheet - ACW 2020 Annual Report

Read further: ACW Balance Sheet Detailed Analysis

The latest balance sheet from annual result of Actinogen Medical Limited showed the company reduced the cash on balance sheet by $-2.60M (-34%). The Net tangible assets of ACW on the balance sheet were at 7.54M which is $-4.46M (-37%) less than previous annual report. The total stockholder equity also decreased by $-4.78M (-30%) compared to previous reporting period.

Balance Sheet Statement Report (2020/2019)

20202019
Cash5.04M7.64M
Total Assets11.94M 16.22M
Long Term Debt--
Total Liabilities1.05M 557.39k
Total Shareholder Equity10.89M15.66M
Net Tangible Assets7.54M12M

Cash Flow Statement - ACW 2020 Annual Report

The 2020 annual cash flow statement of Actinogen Medical Limited showed that the net income increased by $4.56M (46%) compared to previous reporting period. Also the capital expenditure of ACW increased by $0 (0%).

As of 2020, the total cash from investing activities was -22.76k and total cash from financing activities was 282.26k.

Cash Flow Statement Report (2020/2019)

20202019
Net Income-5.33M-9.89M
Capital Expenditures-22.76k-22.76k
Dividends Paid--
Total Cash From From Investing Activities-22.76k71.77k
Total Cash From From Financing Activities282.26k8.17M

Actinogen Medical Limited Annual Report History

Income Statement

Income Statement history of Actinogen Medical Limited (ASX:ACW)

30 Jun 202030 Jun 201930 Jun 201830 Jun 2017
Total Revenue3.52M4.86M3.3M1.42M
Cost Of Revenue----
Gross Profit3.52M4.86M3.3M1.42M
Research Development5.54M10.9M7.74M3.19M
Selling General Administrative2.77M3.09M1.23M939.81k
Non Recurring----
Other Operating Expenses----
Total Operating Expenses8.91M14.47M9.56M4.6M
Operating Income-5.4M-9.61M-6.26M-3.18M
Total Other Income Expense Net65.17k-280.34k30.99k-8.53k
Ebit-5.4M-9.61M-6.26M-3.18M
Interest Expense-28.88k-7.99k-11.46k-8.53k
Income Before Tax-5.33M-9.89M-6.23M-3.19M
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-5.33M-9.89M-6.23M-3.19M
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Charges----
Other Items----
Net Income-5.33M-9.89M-6.23M-3.19M
Net Income Applicable To Common Shares-5.33M-9.89M-6.23M-3.19M

Balance Sheet Statement

Balance Sheet Statement history of Actinogen Medical Limited (ASX:ACW)

30 Jun 202030 Jun 201930 Jun 201830 Jun 2017
Cash5.04M7.64M9.9M1.89M
Net Receivables2.66M4.83M3.49M1.34M
Other Current Assets400.85k---
Total Current Assets8.16M12.53M13.43M5.36M
Property Plant Equipment391.04k--2.27k
Intangible Assets3.35M3.66M4.49M4.84M
Other Assets35.27k35.27k107.04k-
Total Assets11.94M16.22M18.03M10.21M
Accounts Payable46.84k282.82k507.4k649.11k
Other Current Liab583.96k183.11k207.8k24.78k
Total Current Liabilities743.82k557.39k768.25k844.26k
Total Liab1.05M557.39k768.25k844.26k
Common Stock51.32M51.44M43.51M28.86M
Retained Earnings-44.53M-39.2M-29.31M-23.08M
Treasury Stock4.1M3.42M3.05M3.59M
Other Stockholder Equity4.1M3.42M3.05M3.59M
Total Stockholder Equity10.89M15.66M17.26M9.37M
Net Tangible Assets7.54M12M12.77M4.52M
Long Term Debt----

Cash Flow Statement

Cash Flow Statement history of Actinogen Medical Limited (ASX:ACW)

30 Jun 202030 Jun 201930 Jun 201830 Jun 2017
Net Income-5.33M-9.89M-6.23M-3.19M
Depreciation412.93k353.5k356.04k360.62k
Change To Netincome194.49k604.85k197.07k109.46k
Change To Account Receivables1.77M-1.36M-2.16M1.59M
Change To Liabilities75.7k-215.65k-114.46k-20.29k
Change To Operating Activities24.7k4.79k38.45k40.34k
Total Cash From Operating Activities-2.86M-10.5M-7.91M-1.11M
Capital Expenditures-22.76k-22.76k-274-1.02k
Total Cashflows From Investing Activities-22.76k71.77k1.95M1.98M
Net Borrowings-77.74k-77.74k-77.74k-77.74k
Total Cash From Financing Activities282.26k8.17M13.96M270k
Change In Cash-2.6M-2.26M8M1.14M
Issuance Of Stock360k8.48M14.76M270k
Dividends Paid----